IL118007A0 - Isoxazoline compounds pharmaceutical compositions containing them and their use - Google Patents

Isoxazoline compounds pharmaceutical compositions containing them and their use

Info

Publication number
IL118007A0
IL118007A0 IL11800796A IL11800796A IL118007A0 IL 118007 A0 IL118007 A0 IL 118007A0 IL 11800796 A IL11800796 A IL 11800796A IL 11800796 A IL11800796 A IL 11800796A IL 118007 A0 IL118007 A0 IL 118007A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
isoxazoline compounds
compounds pharmaceutical
isoxazoline
Prior art date
Application number
IL11800796A
Other languages
English (en)
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL118007A0 publication Critical patent/IL118007A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11800796A 1995-05-24 1996-04-23 Isoxazoline compounds pharmaceutical compositions containing them and their use IL118007A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44959795A 1995-05-24 1995-05-24
US58694096A 1996-01-11 1996-01-11

Publications (1)

Publication Number Publication Date
IL118007A0 true IL118007A0 (en) 1996-08-04

Family

ID=27035737

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11800796A IL118007A0 (en) 1995-05-24 1996-04-23 Isoxazoline compounds pharmaceutical compositions containing them and their use

Country Status (9)

Country Link
EP (1) EP0832077B1 (de)
JP (1) JPH11511745A (de)
AR (1) AR002996A1 (de)
AT (1) ATE208764T1 (de)
AU (1) AU5876196A (de)
CA (1) CA2222050A1 (de)
DE (1) DE69617010T2 (de)
IL (1) IL118007A0 (de)
WO (1) WO1996037482A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602646D0 (sv) * 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
JP2000516230A (ja) * 1996-08-15 2000-12-05 デュポン ファーマシューティカルズ カンパニー Iib/iiia拮抗薬としての環状カルバメート類およびイソオキサゾリジン類
US5998424A (en) 1997-06-19 1999-12-07 Dupont Pharmaceuticals Company Inhibitors of factor Xa with a neutral P1 specificity group
EE9900584A (et) 1997-06-19 2000-08-15 Dupont Pharmaceuticals Company Neutraalse P1 spetsiifilisusrühmaga faktori Xa inhibiitorid
US6319937B1 (en) * 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
DE69411584T2 (de) * 1993-11-24 1998-12-17 Du Pont Merck Pharma Isoxazoline derivate anwendbar als fibrinogen rezeptor antagonisten

Also Published As

Publication number Publication date
WO1996037482A1 (en) 1996-11-28
JPH11511745A (ja) 1999-10-12
ATE208764T1 (de) 2001-11-15
AU5876196A (en) 1996-12-11
EP0832077B1 (de) 2001-11-14
EP0832077A1 (de) 1998-04-01
CA2222050A1 (en) 1996-11-28
DE69617010D1 (de) 2001-12-20
DE69617010T2 (de) 2002-06-27
AR002996A1 (es) 1998-05-27

Similar Documents

Publication Publication Date Title
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
IL121621A0 (en) Neurotrophic compounds pharmaceutical compositions containing them and their use
IL114622A (en) 5-membered heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
HUP9602056A3 (en) Novel pharmaceutical composition containing phenofibrate
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL124994A (en) Taxoids preparation thereof and pharmaceutical compositions containing same
AP9701093A0 (en) Novel taxoids preparation thereof and pharmaceutical compositions containing same
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
CZ99396A3 (en) Macrolide compounds and pharmaceutical composition containing thereof
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL113389A0 (en) 1,4-Benzodiazepine compounds, pharmaceutical compositions containing them, their preparation and use
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
HUP9901452A3 (en) Bicyclic-aromatic compounds and pharmaceutical compositions containing them
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
AP9701094A0 (en) Novel taxoids preparation thereof and pharmaceutical compositions containing same
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118007A0 (en) Isoxazoline compounds pharmaceutical compositions containing them and their use
IL116082A0 (en) Oxazoles their preparation and pharmaceutical compositions containing them
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
IL123424A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them